Skip to main content

Sabirmedical appoints Wolfgang Reim as Chairman of the Board

By 18 de October de 2011November 18th, 2020No Comments
< Back to news

Sabirmedical appoints Wolfgang Reim as Chairman of the Board

Sabirmedical, a medical technology company –based at the Barcelona Scientific Park– focused on methods for non-invasive measurement of vital body parameters today announces the appointment industry veteran Wolfgang Reim as Chairman of the Board of Directors. Ysios Capital Partners led the €6 millon Series A financing in 2010 joined by La Caixa and Axis-ICO.

Reim brings a wealth of experience from his previous executive positions in industry-leading medical device and technology companies. Reim was Chief Executive Officer of Dräger Medical AG & Co. KG and Member of the Executive Board of Drägerwerk AG for 7 years. Before, he was President of the US-based Ultrasound Division at Siemens Healthcare and served in other leadership positions in areas like magnetic resonance, mammography, urology, lithotripsy, surgery, mobile X-ray and the accessories business.

Previous to these responsabilities Dr. Reim was at the IBM and the Siemens Research and Development Centers. Dr. Reim currently serves on the boards of directors Carl Zeiss Meditec AG, GN Store Nord A/S, Esaote SpA and Elekta AB. Dr. Reim studied Mathematics and Physics at the ETH Zürich and holds a PhD degree in Experimental Solid-State Physics.

“Wolfgang’s experience, strategic vision and proven abilities to drive value out of the unique medtech innovations will be very valuable for Sabirmedical’s product pipeline in the immediate future”, said Josep Ll. Sanfeliu former Chairman of the Board of Sabirmedical and partner at Ysios.

Wolfgang Reim has been monitoring the company’s development for the last year in close contact with its founders and investors. His role as Chairman will focus on strategic decisions related to product development and corporate and business development opportunities.

Reim said “Sabirmedical is developing a unique non-invasive platform which has the potential to address an unmet medical need in areas so relevant to patients such as blood pressure, hypertension and diabetis. It is with pleasure that I take on the role of Chairman of the Board to assist Sabirmedical to become a relevant innovative medtech player in the industry, as I believe that together we will improve the standard of care for millions of patients worldwide and provide healthcare systems with effective and more efficient medical solutions.